Stocks · Health care · Pharmaceutical Preparations

Tonix Pharmaceuticals Holding Corp.

TNXP Clue Score71
United States Fiscal year ends December CIK 0001430306 Results filed 15 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Seth Lederman
27 Aug 2026
Chief Executive Officer
Buy indirect
2,000
$13.79
$27.58K
Richard H Bagger
20 Aug 2026
Director
Buy
1,000
$12.60
$12.60K
Carolyn E. Taylor
12 Jun 2026
Director
Buy
1,415
$10.55
$14.93K
Seth Lederman
9 Jun 2026
Chief Executive Officer
Buy
5,000
$11.79
$58.95K
Richard Newcomb Stillwell
8 Jun 2026
Director
Buy
5,000
$11.65
$58.25K
Seth Lederman
31 Mar 2026
Chief Executive Officer
Buy indirect
5,000
$12.62
$63.10K
Seth Lederman
18 Mar 2026
Chief Executive Officer
Buy indirect
15,000
$14.89
$223.35K
Carolyn E. Taylor
21 Aug 2025
Director
Buy
418
$36.03
$15.06K
James Treco
20 Aug 2025
Director
Buy
250
$36.00
$9.00K
Seth Lederman
15 May 2025
Chief Executive Officer
Buy
4,000
$21.55
$86.20K
Seth Lederman
29 Jun 2022
Chief Executive Officer
Buy indirect
20,000
$1.71
$34.20K
Seth Lederman
25 Mar 2022
Chief Executive Officer
Buy
100,000
$0.25
$24.50K
Seth Lederman
28 Sep 2021
Chief Executive Officer
Buy
12,000
$0.61
$7.32K
Daniel Wintner Goodman
25 May 2021
Director
Buy
5,000
$1.12
$5.60K
Seth Lederman
24 Mar 2021
Chief Executive Officer
Buy indirect
16,733
$1.32
$22.09K
Seth Lederman
30 Dec 2020
Chief Executive Officer
Buy
35,000
$0.68
$23.80K
James Treco
31 Aug 2020
Director
Buy
5,500
$0.89
$4.90K
Margaret Smith Bell
20 Aug 2020
Director
Buy
5,391
$0.93
$5.00K
Gregory M Sullivan
17 Aug 2020
Chief Medical Officer
Buy
20,000
$1.03
$20.60K
James Treco
14 Aug 2020
Director
Buy
4,500
$1.06
$4.77K
Richard H Bagger
13 Aug 2020
Director
Buy
10,000
$0.91
$9.10K
Seth Lederman
13 Aug 2020
Chief Executive Officer
Buy indirect
60,000
$0.91
$54.60K
Adeoye Y Olukotun
13 Aug 2020
Director
Buy
5,350
$0.94
$5.03K
Seth Lederman
3 Dec 2019
Chief Executive Officer
Buy indirect
20,000
$1.16
$23.18K
Seth Lederman
29 Mar 2019
Chief Executive Officer
Buy indirect
5,000
$2.49
$12.44K
Seth Lederman
26 Mar 2019
Chief Executive Officer
Buy indirect
25,000
$2.38
$59.38K
Seth Lederman
29 Jun 2018
Chief Executive Officer
Buy
500
$4.64
$2.32K
Seth Lederman
28 Jun 2018
Chief Executive Officer
Buy
500
$4.58
$2.29K
Seth Lederman
27 Jun 2018
Chief Executive Officer
Buy
500
$4.55
$2.28K
Ernest Mario
25 Jun 2018
Director
Buy indirect
16,500
$4.48
$73.92K
Jessica Edgar Morris
14 Jun 2018
Chief Operating Officer
Buy
300
$4.19
$1.26K
Bradley Saenger
14 Jun 2018
Chief Financial Officer
Buy
300
$4.10
$1.23K
Gregory M Sullivan
14 Jun 2018
Chief Medical Officer
Buy
10,000
$3.97
$39.65K
Seth Lederman
12 Jun 2018
Chief Executive Officer
Buy indirect
2,000
$4.37
$8.74K
Seth Lederman
12 Jun 2018
Chief Executive Officer
Buy
1,000
$4.37
$4.37K
John B Rhodes
1 Jun 2018
Director
Buy
7,500
$3.33
$24.98K
Seth Lederman
25 May 2018
Chief Executive Officer
Buy indirect
4,000
$3.17
$12.68K
Seth Lederman
26 Dec 2017
Chief Executive Officer
Buy indirect
5,300
$3.61
$19.13K
Seth Lederman
17 Aug 2017
Chief Executive Officer
Buy indirect
15,000
$3.00
$45.07K
Seth Lederman
16 Aug 2017
Chief Executive Officer
Buy indirect
5,000
$2.99
$14.95K
Seth Lederman
30 Jun 2017
Chief Executive Officer
Buy indirect
5,000
$4.33
$21.64K
Seth Lederman
26 Jun 2017
Chief Executive Officer
Buy indirect
5,000
$4.40
$22.00K
Seth Lederman
20 Jun 2017
Chief Executive Officer
Buy indirect
20,000
$4.22
$84.40K
Ernest Mario
23 Nov 2016
Director
Buy indirect
120,000
$0.41
$48.60K
Seth Lederman
21 Nov 2016
Chief Executive Officer
Buy indirect
98,000
$0.43
$41.92K

What was left out

Form 4 filings counted 184
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 73,284
Sales filed before the plan box existed 7
History held since 5 May 2011